848139-78-6Relevant articles and documents
Synthesis method of pyrrotinib maleate intermediate
-
, (2021/09/04)
The invention relates to the technical field of medicine synthesis, in particular to a synthesis method of a pyrrotinib maleate intermediate. The synthesis method comprises the following steps: by taking a formula II as an initial raw material, reacting the formula II with cyanoacetamide under the action of a sulfonic acid compound to obtain a compound shown in a formula III; carrying out heating reflux reaction on the compound as shown in the formula III, 4-nitro-3-ethoxyaniline and triethyl orthoformate, and obtaining a solid intermediate product after the reaction is finished; subjecting the obtained solid intermediate product and Lewis acid to a heating ring closing reaction to obtain a compound shown in a formula IV; and carrying out reduction reaction on the compound as shown in the formula IV, hydrazine hydrate and activated carbon under the action of a catalyst to prepare the compound as shown in the formula I, namely the pyrrotinib maleate intermediate disclosed by the invention. The method is short in reaction route, high in yield, simple and convenient to operate, free of extreme reaction conditions and expensive raw materials, lower in production cost and beneficial to industrial production.
Preparation method of 3-cyano-4-anilino-6-aminoquinoline derivative
-
Paragraph 0030-0032; 0036-0043, (2020/11/12)
The invention discloses a preparation method of a 3-cyano-4-anilino-6-aminoquinoline derivative. According to the preparation method, zinc nitrate is carefully selected as a specific catalyst and is combined with a specific solvent and a specific reaction temperature, so that few byproducts are produced in the preparation process, products of -CN hydrolysis and side chain amide hydrolysis in quinoline rings do not exist in the products basically, and the yield of a target product is high. The method has the advantages of mild reaction process, high safety and no use of specific equipment, andis suitable for industrial production. The preparation method has the advantages of simplicity, cheap and easily available raw materials, mild reaction conditions, no need of large equipment, high final product yield and high purity, and is suitable for industrial popularization.
Design, synthesis and biological study of potent and covalent HER-2 tyrosine kinase inhibitors with low cytotoxicity in vitro
Jin, Shuyu,Sun, Xiuyun,Liu, Dan,Xie, Hua,Rao, Yu
, p. 1333 - 1345 (2019/05/06)
The discovery and development of a novel HER-2 tyrosine kinase inhibitor for the treatment of HER2-positive breast cancer are presented in this article. EGFR family has been recognized as a crucial meditator in the cancer progression; HER-2 tyrosine kinase was one of the members among them. In the effort to explore potent HER-2 inhibitors, a novel series of 4-anilino-3-cyanoquinoline derivatives have been designed, synthesized and evaluated. Most compounds possessed modest proliferation inhibition on SK-BR-3 cell line and HER-2 kinase. Compound 16 appeared to be the most potent compound (HER-2 kinase IC50: 19.4?nM, SK-BR-3 IC50: 94?nM). In the experiment of cellular cytotoxicity assay, compound 16 shows a much lower cytotoxicity than neratinib on Beas-2b cell line (Human bronchial epithelial cells). In conclusion, compound 16 would be a promising lead compound for further anti-breast cancer drug discovery.